BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9706720)

  • 1. Long-term glioblastoma multiforme survivors: a population-based study.
    Scott JN; Rewcastle NB; Brasher PM; Fulton D; Hagen NA; MacKinnon JA; Sutherland G; Cairncross JG; Forsyth P
    Can J Neurol Sci; 1998 Aug; 25(3):197-201. PubMed ID: 9706720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which glioblastoma multiforme patient will become a long-term survivor? A population-based study.
    Scott JN; Rewcastle NB; Brasher PM; Fulton D; MacKinnon JA; Hamilton M; Cairncross JG; Forsyth P
    Ann Neurol; 1999 Aug; 46(2):183-8. PubMed ID: 10443883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the long-term survival of patients with intracranial glioblastoma multiforme overstated?
    McLendon RE; Halperin EC
    Cancer; 2003 Oct; 98(8):1745-8. PubMed ID: 14534892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosis.
    Kozak KR; Moody JS
    Neuro Oncol; 2009 Dec; 11(6):833-41. PubMed ID: 19332771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior malignancies in patients harboring glioblastoma: an institutional case-study of 2164 patients.
    Zacharia BE; DiStefano N; Mader MM; Chohan MO; Ogilvie S; Brennan C; Gutin P; Tabar V
    J Neurooncol; 2017 Sep; 134(2):245-251. PubMed ID: 28551847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme.
    Shinojima N; Kochi M; Hamada J; Nakamura H; Yano S; Makino K; Tsuiki H; Tada K; Kuratsu J; Ishimaru Y; Ushio Y
    J Neurosurg; 2004 Aug; 101(2):219-26. PubMed ID: 15309911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distress persists in long-term brain tumor survivors with glioblastoma multiforme.
    Keir ST; Farland MM; Lipp ES; Friedman HS
    J Cancer Surviv; 2008 Dec; 2(4):269-74. PubMed ID: 18958627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999.
    Chakrabarti I; Cockburn M; Cozen W; Wang YP; Preston-Martin S
    Cancer; 2005 Dec; 104(12):2798-806. PubMed ID: 16288487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do Long-Term Survivor Primary Glioblastoma Patients Harbor IDH1 Mutations?
    Sarmiento JM; Mukherjee D; Black KL; Fan X; Hu JL; Nuno MA; Patil CG
    J Neurol Surg A Cent Eur Neurosurg; 2016 May; 77(3):195-200. PubMed ID: 26935296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors.
    Burton EC; Lamborn KR; Forsyth P; Scott J; O'Campo J; Uyehara-Lock J; Prados M; Berger M; Passe S; Uhm J; O'Neill BP; Jenkins RB; Aldape KD
    Clin Cancer Res; 2002 Jan; 8(1):180-7. PubMed ID: 11801556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of gender on the survival of patients with glioblastoma.
    Tian M; Ma W; Chen Y; Yu Y; Zhu D; Shi J; Zhang Y
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30305382
    [No Abstract]   [Full Text] [Related]  

  • 12. Glioblastoma multiforme with long term survival.
    Deb P; Sharma MC; Mahapatra AK; Agarwal D; Sarkar C
    Neurol India; 2005 Sep; 53(3):329-32. PubMed ID: 16230803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiologic and molecular prognostic review of glioblastoma.
    Thakkar JP; Dolecek TA; Horbinski C; Ostrom QT; Lightner DD; Barnholtz-Sloan JS; Villano JL
    Cancer Epidemiol Biomarkers Prev; 2014 Oct; 23(10):1985-96. PubMed ID: 25053711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress Toward Long-Term Survivors of Glioblastoma.
    Cantrell JN; Waddle MR; Rotman M; Peterson JL; Ruiz-Garcia H; Heckman MG; Quiñones-Hinojosa A; Rosenfeld SS; Brown PD; Trifiletti DM
    Mayo Clin Proc; 2019 Jul; 94(7):1278-1286. PubMed ID: 31230743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term survivors of glioblastoma multiforme: clinical and molecular characteristics.
    Morita M; Rosenblum MK; Bilsky MH; Fraser RA; Rosenfeld MR
    J Neurooncol; 1996 Mar; 27(3):259-66. PubMed ID: 8847560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).
    Vordermark D; Ruprecht K; Rieckmann P; Roggendorf W; Vince GH; Warmuth-Metz M; Kölbl O; Flentje M
    BMC Cancer; 2006 Oct; 6():247. PubMed ID: 17049083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term survivors of glioblastoma: a closer look.
    Gately L; McLachlan SA; Philip J; Ruben J; Dowling A
    J Neurooncol; 2018 Jan; 136(1):155-162. PubMed ID: 29079955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of more than 20 years survival with glioblastoma, and development of cavernous angioma as a delayed complication of radiotherapy.
    Fukushima S; Narita Y; Miyakita Y; Ohno M; Takizawa T; Takusagawa Y; Mori M; Ichimura K; Tsuda H; Shibui S
    Neuropathology; 2013 Oct; 33(5):576-81. PubMed ID: 23406431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival of patients with glioblastoma multiforme (GBM).
    Smoll NR; Schaller K; Gautschi OP
    J Clin Neurosci; 2013 May; 20(5):670-5. PubMed ID: 23352352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.